Related Experiment Videos
Comorbidity-based payment methodology for Medicaid enrollees with HIV/AIDS
S H Fakhraei1, J J Kaelin, R Conviser
1Center for Health Program Development and Management, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA. fakhraei@chpdm.umbc.edu
Health Care Financing Review
|December 26, 2002
Summary
Managed care organizations (MCOs) face financial risks with individuals with human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS). A new statistical model accurately predicts healthcare costs for PWHA, improving MCO financial protection.
Area of Science:
- Health Economics
- Public Health
- Biostatistics
Background:
- Managed care organizations (MCOs) may experience financial losses due to the high healthcare costs associated with persons with human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) (PWHA).
- Traditional risk-adjustment methods may not adequately account for the complex healthcare needs and associated costs of PWHA.
- Understanding the drivers of healthcare expenditure variations among PWHA is crucial for financial sustainability in managed care settings.
Purpose of the Study:
- To develop and validate a statistical model identifying key comorbidities contributing to healthcare cost variations in PWHA.
- To compare capitation payments generated by the new model against actual care costs across different risk groups.
- To assess the effectiveness of the proposed model in protecting MCOs from financial losses related to HIV/AIDS enrollees.
Main Methods:
- Development of a statistical model to analyze healthcare costs in PWHA.
- Classification of individuals into distinct cost groups to simulate selection biases within MCOs.
- Comparison of capitation payments derived from various methodologies, including the new model and traditional approaches.
Main Results:
- The developed statistical model demonstrated a close alignment between predicted capitation payments and the actual costs of care for PWHA.
- Specific comorbidities were identified as significant contributors to healthcare cost variations.
- The proposed model offers a more accurate financial protection mechanism for MCOs compared to existing risk-adjustment methods.
Conclusions:
- The new statistical model provides a more precise method for capitation payments for HIV/AIDS enrollees.
- Implementing this model can enhance the financial stability of MCOs managing populations with HIV/AIDS.
- This approach offers improved risk-adjustment, better protecting MCOs against financial losses from PWHA.